The chronic administration of cabergoline normalizes androgen secretion and improves menstrual cyclicity in women with polycystic ovary syndrome.

Paoletti, A M

The chronic administration of cabergoline normalizes androgen secretion and improves menstrual cyclicity in women with polycystic ovary syndrome. [electronic resource] - Fertility and sterility Oct 1996 - 527-32 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial

0015-0282

10.1016/s0015-0282(16)58563-x doi


Adult
Androgens--metabolism
Cabergoline
Dopamine Agonists--therapeutic use
Double-Blind Method
Ergolines--therapeutic use
Female
Follicle Stimulating Hormone--blood
Humans
Luteinizing Hormone--blood
Menstrual Cycle--drug effects
Polycystic Ovary Syndrome--blood